ACT Capital Management
Latest statistics and disclosures from Act Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are KRYS, CVX, XOM, ABVX, TGTX, and represent 43.21% of Act Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ABVX (+$8.6M), CVX (+$8.5M), TGTX (+$8.0M), VKTX (+$7.3M), CELC (+$6.3M), AMZN (+$5.7M), NUVB (+$5.5M), CYTK, Celcuity Inc Com Mar 20 26 $50 Call, GPCR.
- Started 47 new stock positions in KYTX, CELC, PATH, FIGR, ABVX, BW, NKTR, CAPR, REPL, AMZN.
- Reduced shares in these 10 stocks: STAA, AXSM, ADTN, CLSD, ARWR, DVN, VTLE, ARCT, Eiger Biopharmaceuticals, VRNA.
- Sold out of its positions in ADTN, ADAPY, AIRS, Aravive, ARCT, Aspira Womens Health, Atara Biotherapeutics, AXSM, Biolinerx, Cbdmd.
- Act Capital Management was a net buyer of stock by $49M.
- Act Capital Management has $124M in assets under management (AUM), dropping by 70.68%.
- Central Index Key (CIK): 0001442273
Tip: Access up to 7 years of quarterly data
Positions held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Act Capital Management
Act Capital Management holds 58 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 12.1 | $15M | +3% | 61k | 246.54 |
|
| Chevron Corporation (CVX) | 9.7 | $12M | +248% | 79k | 152.41 |
|
| Exxon Mobil Corporation (XOM) | 8.0 | $9.9M | 83k | 120.34 |
|
|
| Abivax Sponsored Ads (ABVX) | 7.0 | $8.6M | NEW | 64k | 134.85 |
|
| Tg Therapeutics (TGTX) | 6.5 | $8.0M | NEW | 269k | 29.81 |
|
| Viking Therapeutics (VKTX) | 5.9 | $7.3M | NEW | 206k | 35.18 |
|
| Celcuity (CELC) | 5.1 | $6.3M | NEW | 63k | 99.74 |
|
| Amazon (AMZN) | 4.6 | $5.7M | NEW | 25k | 230.82 |
|
| Nuvation Bio Com Cl A (NUVB) | 4.4 | $5.5M | NEW | 611k | 8.96 |
|
| Arrowhead Pharmaceuticals (ARWR) | 4.0 | $5.0M | -32% | 75k | 66.39 |
|
| Cytokinetics (CYTK) | 3.3 | $4.1M | NEW | 65k | 63.54 |
|
| Celcuity Inc Com Mar 20 26 $50 Call Option | 2.5 | $3.0M | NEW | 31k | 99.74 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 2.2 | $2.7M | NEW | 39k | 69.55 |
|
| Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC) | 1.9 | $2.4M | NEW | 34k | 68.36 |
|
| Figure Technology Solutions Com Cl A (FIGR) | 1.9 | $2.3M | NEW | 58k | 40.84 |
|
| Spotify Technology SHS (SPOT) | 1.9 | $2.3M | NEW | 4.0k | 580.71 |
|
| Energy Transfer Com Ut Ltd Ptn (ET) | 1.8 | $2.2M | +4% | 133k | 16.49 |
|
| Nektar Therapeutics Com New (NKTR) | 1.8 | $2.2M | NEW | 51k | 42.28 |
|
| Olema Pharmaceuticals (OLMA) | 1.1 | $1.3M | NEW | 54k | 25.00 |
|
| International Business Machines (IBM) | 1.1 | $1.3M | NEW | 4.5k | 296.21 |
|
| STAAR Surgical Company (STAA) | 1.0 | $1.3M | -75% | 56k | 23.09 |
|
| Celcuity Inc Com Mar 20 26 $35 Call Option | 1.0 | $1.2M | NEW | 13k | 99.74 |
|
| Regenxbio Inc equity us cm (RGNX) | 1.0 | $1.2M | NEW | 83k | 14.40 |
|
| Bloom Energy Corp Com Cl A (BE) | 0.9 | $1.1M | NEW | 13k | 86.89 |
|
| Warrior Met Coal (HCC) | 0.9 | $1.1M | NEW | 12k | 88.17 |
|
| EOG Resources (EOG) | 0.8 | $1.1M | NEW | 10k | 105.01 |
|
| Sandisk Corp (SNDK) | 0.7 | $831k | NEW | 3.5k | 237.38 |
|
| Devon Energy Corporation (DVN) | 0.7 | $806k | -73% | 22k | 36.63 |
|
| Uipath Inc Cl A (PATH) | 0.6 | $770k | NEW | 47k | 16.39 |
|
| Kura Oncology (KURA) | 0.6 | $768k | NEW | 74k | 10.39 |
|
| Teva Pharmaceutical Industries Sponsored Ads (TEVA) | 0.6 | $718k | NEW | 23k | 31.21 |
|
| Replimune Group (REPL) | 0.5 | $598k | NEW | 62k | 9.72 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $529k | NEW | 12k | 44.05 |
|
| Apogee Therapeutics (APGE) | 0.4 | $528k | NEW | 7.0k | 75.48 |
|
| Crescent Energy Company Cl A Com (CRGY) | 0.4 | $514k | NEW | 61k | 8.39 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.3 | $390k | NEW | 3.0k | 130.06 |
|
| Palisade Bio (PALI) | 0.3 | $353k | NEW | 150k | 2.35 |
|
| Alpha Cognition (ACOG) | 0.3 | $335k | NEW | 52k | 6.50 |
|
| Liquidia Corporation Com New (LQDA) | 0.2 | $293k | NEW | 8.5k | 34.49 |
|
| Kyverna Therapeutics (KYTX) | 0.2 | $236k | NEW | 25k | 9.40 |
|
| Babcock & Wilcox Enterpr (BW) | 0.2 | $231k | NEW | 37k | 6.34 |
|
| Aldeyra Therapeutics (ALDX) | 0.2 | $212k | NEW | 41k | 5.18 |
|
| Terra Innovatum Global N V Ord Shs (NKLR) | 0.2 | $208k | NEW | 45k | 4.62 |
|
| Praxis Precision Medicines Com New (PRAX) | 0.2 | $206k | NEW | 700.00 | 294.74 |
|
| Esperion Therapeutics (ESPR) | 0.1 | $176k | NEW | 48k | 3.70 |
|
| Lightspeed Commerce Sub Vtg Shs (LSPD) | 0.1 | $151k | NEW | 13k | 12.08 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $120k | NEW | 13k | 9.32 |
|
| Travere Therapeutics (TVTX) | 0.1 | $115k | NEW | 3.0k | 38.21 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $109k | NEW | 9.0k | 12.08 |
|
| Weyerhaeuser Co Mtn Be Com New (WY) | 0.1 | $107k | NEW | 4.5k | 23.69 |
|
| Stratasys (SSYS) | 0.1 | $87k | -71% | 10k | 8.68 |
|
| Biohaven (BHVN) | 0.1 | $85k | NEW | 7.5k | 11.29 |
|
| Grayscale Bitcoin Mini Tr Etf Shs New (BTC) | 0.1 | $70k | NEW | 1.8k | 38.73 |
|
| Capricor Therapeutics Com New (CAPR) | 0.0 | $43k | NEW | 1.5k | 28.86 |
|
| Envveno Medical (NVNO) | 0.0 | $37k | -71% | 115k | 0.32 |
|
| Yalla Group Sponsored Ads (YALA) | 0.0 | $35k | -62% | 5.0k | 6.94 |
|
| Pds Biotechnology Ord (PDSB) | 0.0 | $23k | +150% | 30k | 0.77 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $20k | NEW | 1.5k | 13.18 |
|
Past Filings by Act Capital Management
SEC 13F filings are viewable for Act Capital Management going back to 2021
- Act Capital Management 2025 Q4 filed Feb. 17, 2026
- Act Capital Management 2022 Q3 filed Nov. 3, 2022
- Act Capital Management 2022 Q2 filed Aug. 12, 2022
- Act Capital Management 2022 Q1 filed May 11, 2022
- Act Capital Management 2021 Q4 filed Feb. 3, 2022
- ACT Capital 2021 Q3 filed Nov. 16, 2021
- ACT Capital Management 2021 Q2 filed Aug. 16, 2021